<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Huang Y</submitter><funding>Multiple Sclerosis Society</funding><pagination>103175</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8313796</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>55</volume><pubmed_abstract>&lt;h4>Background &amp; methods&lt;/h4>We conducted an online COVID-19 survey as the vaccines became available, utilising the UK MS Register, to understand people with multiple sclerosis (pwMS) views on COVID-19 vaccination and the subsequent vaccine uptake rates.&lt;h4>Results &amp; conclusion&lt;/h4>94.4% of 3191 pwMS surveyed indicated they would get a COVID-19 vaccine, while 5.6% would not. PwMS who have previously had an influenza vaccine, increasing age and the perception of having sufficient information about the vaccine were associated with increased likelihood of getting a vaccine. 51.7% of 3191 pwMS completed a follow-up survey indicating they received at least 1 dose of a COVID-19 vaccine. The proportion having had the vaccination based on their prior opinions was 53.2% in 'Yes' group and 27.0% in 'No' group, the latter reflecting a change based on their initial views. More information on COVID-19 vaccine safety in pwMS would be helpful for people to make informed decisions.</pubmed_abstract><journal>Multiple sclerosis and related disorders</journal><pubmed_title>Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey.</pubmed_title><pmcid>PMC8313796</pmcid><funding_grant_id>001</funding_grant_id><pubmed_authors>Middleton RM</pubmed_authors><pubmed_authors>Rodgers WJ</pubmed_authors><pubmed_authors>Tuite-Dalton KA</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Ford DV</pubmed_authors><pubmed_authors>Nicholas R</pubmed_authors><pubmed_authors>Group MRR</pubmed_authors><pubmed_authors>Baheerathan A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Willingness to receive a COVID-19 vaccine in people with multiple sclerosis - UK MS Register survey.</name><description>&lt;h4>Background &amp; methods&lt;/h4>We conducted an online COVID-19 survey as the vaccines became available, utilising the UK MS Register, to understand people with multiple sclerosis (pwMS) views on COVID-19 vaccination and the subsequent vaccine uptake rates.&lt;h4>Results &amp; conclusion&lt;/h4>94.4% of 3191 pwMS surveyed indicated they would get a COVID-19 vaccine, while 5.6% would not. PwMS who have previously had an influenza vaccine, increasing age and the perception of having sufficient information about the vaccine were associated with increased likelihood of getting a vaccine. 51.7% of 3191 pwMS completed a follow-up survey indicating they received at least 1 dose of a COVID-19 vaccine. The proportion having had the vaccination based on their prior opinions was 53.2% in 'Yes' group and 27.0% in 'No' group, the latter reflecting a change based on their initial views. More information on COVID-19 vaccine safety in pwMS would be helpful for people to make informed decisions.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Oct</publication><modification>2024-11-20T03:54:34.038Z</modification><creation>2022-02-11T12:04:29.867Z</creation></dates><accession>S-EPMC8313796</accession><cross_references><pubmed>34343866</pubmed><doi>10.1016/j.msard.2021.103175</doi></cross_references></HashMap>